𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer

✍ Scribed by Dowsett, M.; Smithers, D.; Moore, J.; Trunet, P.F.; Coombes, R.C.; Powles, T.J.; Rubens, R.; Smith, I.E.

Book ID
122448765
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
826 KB
Volume
30
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of the potent aromatase inhibitor
Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma
✍ Luis A. M. Costa; Michael S. Kopreski; Laurence M. Demers; Vernon M. Chinchilli; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 1 views

## Background: Fadrozole hydrochloride (cgs 16949a) is a highly potent, nonsteroidal aromatase inhibitor that significantly lowers estrogen levels in postmenopausal women and can be effective therapy for patients with advanced hormone-dependent breast carcinoma. circulating estradiol, estrone, and